SLS SELLAS Life Sciences Group, Inc.
Nasdaq · SEC CIK 1390478 · EDGAR
- Bought, last 12 months
- $100.8K 1 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 63 since 2021-12-03, latest 2026-06-18 16:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Kalin Katherine Bach | Dir | $100.8K | — |
| Stergiou Angelos M. | Pres, CEO, Dir | — | — |
| Burns John Thomas | CFO | — | — |
| CICIC DRAGAN | SVP, Chief Development Off | — | — |
| Varian John | Dir | — | — |
| Wasman Jane | Dir | — | — |
| SCHEINBERG DAVID A | Dir | — | — |
| VAN NOSTRAND ROBERT L | Dir | — | — |
Transactions 61
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 16:30 | 2026-06-16 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +1.06M | 1.76M | +153% | $0 | |
| 2026-01-09 | 2026-01-07 | SLS | Wasman Jane | Dir | A - Grant | $0.00 | +50.0K | 92.9K | +117% | $0 | |
| 2026-01-09 | 2026-01-07 | SLS | Kalin Katherine Bach | Dir | A - Grant | $0.00 | +50.0K | 154.4K | +48% | $0 | |
| 2026-01-09 | 2026-01-07 | SLS | VAN NOSTRAND ROBERT L | Dir | A - Grant | $0.00 | +50.0K | 82.9K | +152% | $0 | |
| 2026-01-09 | 2026-01-07 | SLS | Varian John | Dir | A - Grant | $0.00 | +50.0K | 72.9K | +218% | $0 | |
| 2026-01-09 | 2026-01-07 | SLS | Burns John Thomas | CFO | A - Grant | $0.00 | +300.0K | 554.3K | +118% | $0 | |
| 2026-01-09 | 2026-01-07 | SLS | SCHEINBERG DAVID A | Dir | A - Grant | $0.00 | +50.0K | 73.1K | +217% | $0 | |
| 2026-01-09 | 2026-01-07 | SLS | CICIC DRAGAN | SVP, Chief Development Off | A - Grant | $0.00 | +300.0K | 557.8K | +116% | $0 | |
| 2025-12-05 | 2025-12-03 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | J - Other | $1.50 | -187.1K | 687.0K | -21% | -$280.6K | |
| 2025-12-05 | 2025-12-03 | SLS | CICIC DRAGAN | SVP, Chief Development Off | J - Other | $1.50 | -63.8K | 257.8K | -20% | -$95.7K | |
| 2025-12-05 | 2025-12-03 | SLS | Burns John Thomas | CFO | J - Other | $1.50 | -58.6K | 254.3K | -19% | -$87.9K | |
| 2025-11-21 | 2025-11-19 | SLS | Kalin Katherine Bach | Dir | P - Purchase | $1.59 | +63.4K | 104.4K | +155% | +$100.8K | |
| 2025-06-13 | 2025-06-12 | SLS | VAN NOSTRAND ROBERT L | Dir | P - Purchase | $1.48 | +10.0K | 20.4K | +96% | +$14.8K | |
| 2025-06-02 | 2025-05-30 | SLS | Wasman Jane | Dir | P - Purchase | $1.69 | +20.0K | 30.4K | +192% | +$33.8K | |
| 2025-05-22 | 2025-05-22 | SLS | Kalin Katherine Bach | Dir | P - Purchase | $1.80 | +20.0K | 41.0K | +95% | +$36.0K | |
| D | 2025-01-14 | 2025-01-10 | SLS | SCHEINBERG DAVID A | Dir | A - Grant | $0.00 | +12.5K | 23.1K | +118% | $0 |
| D | 2025-01-14 | 2025-01-10 | SLS | VAN NOSTRAND ROBERT L | Dir | A - Grant | $0.00 | +12.5K | 22.9K | +120% | $0 |
| DM | 2025-01-14 | 2025-01-10 | SLS | Burns John Thomas | CFO | A - Grant | $0.00 | +194.3K | 299.1K | +185% | $0 |
| D | 2025-01-14 | 2025-01-10 | SLS | Kalin Katherine Bach | Dir | A - Grant | $0.00 | +12.5K | 21.0K | +147% | $0 |
| DM | 2025-01-14 | 2025-01-10 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +500.9K | 615.1K | +438% | $0 |
| DM | 2025-01-14 | 2025-01-10 | SLS | CICIC DRAGAN | SVP, Chief Development Off | A - Grant | $0.00 | +194.3K | 228.3K | +571% | $0 |
| D | 2025-01-14 | 2025-01-10 | SLS | Wasman Jane | Dir | A - Grant | $0.00 | +12.5K | 22.9K | +120% | $0 |
| D | 2025-01-14 | 2025-01-10 | SLS | Varian John | Dir | A - Grant | $0.00 | +12.5K | 22.9K | +120% | $0 |
| 2024-12-05 | 2024-12-04 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | J - Other | $1.13 | -28.3K | 358.1K | -7% | -$32.0K | |
| 2024-12-05 | 2024-12-04 | SLS | CICIC DRAGAN | SVP, Chief Development Off | J - Other | $1.13 | -8,256 | 115.3K | -7% | -$9,329 | |
| 2024-12-05 | 2024-12-04 | SLS | Burns John Thomas | CFO | J - Other | $1.13 | -7,165 | 104.8K | -6% | -$8,096 | |
| D | 2024-01-25 | 2024-01-22 | SLS | Kalin Katherine Bach | Dir | A - Grant | $0.00 | +6,000 | 8,500 | +240% | $0 |
| D | 2024-01-25 | 2024-01-22 | SLS | SCHEINBERG DAVID A | Dir | A - Grant | $0.00 | +6,000 | 10.6K | +131% | $0 |
| D | 2024-01-25 | 2024-01-22 | SLS | Wasman Jane | Dir | A - Grant | $0.00 | +6,000 | 10.4K | +136% | $0 |
| D | 2024-01-25 | 2024-01-22 | SLS | Varian John | Dir | A - Grant | $0.00 | +6,000 | 10.4K | +136% | $0 |
| D | 2024-01-25 | 2024-01-22 | SLS | VAN NOSTRAND ROBERT L | Dir | A - Grant | $0.00 | +6,000 | 10.4K | +136% | $0 |
| D | 2024-01-25 | 2024-01-22 | SLS | Burns John Thomas | CFO | A - Grant | $0.00 | +47.0K | 101.9K | +86% | $0 |
| D | 2024-01-25 | 2024-01-22 | SLS | Francomano Robert | Chief Commercial Off | A - Grant | $0.00 | +20.0K | 40.9K | +96% | $0 |
| D | 2024-01-25 | 2024-01-22 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +159.0K | 376.4K | +73% | $0 |
| D | 2024-01-25 | 2024-01-22 | SLS | WOOD BARBARA A | EVP, Gen. Counsel, Corp. Sec | A - Grant | $0.00 | +35.0K | 117.2K | +43% | $0 |
| 2023-12-08 | 2023-12-06 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | J - Other | $1.08 | -12.3K | 217.4K | -5% | -$13.2K | |
| 2023-12-08 | 2023-12-06 | SLS | Francomano Robert | Chief Commercial Off | J - Other | $1.08 | -1,082 | 20.9K | -5% | -$1,169 | |
| 2023-12-08 | 2023-12-06 | SLS | Burns John Thomas | CFO | J - Other | $1.08 | -2,929 | 54.9K | -5% | -$3,163 | |
| 2023-12-08 | 2023-12-06 | SLS | WOOD BARBARA A | EVP, Gen. Counsel, Corp. Sec | J - Other | $1.08 | -4,119 | 82.2K | -5% | -$4,449 | |
| D | 2023-02-03 | 2023-02-02 | SLS | Varian John | Dir | A - Grant | $0.00 | +2,500 | 4,400 | +132% | $0 |
| D | 2023-02-03 | 2023-02-02 | SLS | Kalin Katherine Bach | Dir | A - Grant | $0.00 | +2,500 | 2,500 | New | $0 |
| D | 2023-02-03 | 2023-02-02 | SLS | VAN NOSTRAND ROBERT L | Dir | A - Grant | $0.00 | +2,500 | 4,400 | +132% | $0 |
| D | 2023-02-03 | 2023-02-02 | SLS | Wasman Jane | Dir | A - Grant | $0.00 | +2,500 | 4,400 | +132% | $0 |
| D | 2023-02-03 | 2023-02-02 | SLS | WOOD BARBARA A | EVP, Gen. Counsel, Corp. Sec | A - Grant | $0.00 | +20.0K | 76.3K | +35% | $0 |
| D | 2023-02-03 | 2023-02-02 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +58.0K | 219.7K | +36% | $0 |
| D | 2023-02-03 | 2023-02-02 | SLS | Burns John Thomas | CFO | A - Grant | $0.00 | +20.0K | 49.3K | +68% | $0 |
| D | 2023-02-03 | 2023-02-02 | SLS | SCHEINBERG DAVID A | Dir | A - Grant | $0.00 | +2,500 | 4,582 | +120% | $0 |
| D | 2023-02-03 | 2023-02-02 | SLS | Francomano Robert | Chief Commercial Off | A - Grant | $0.00 | +12.0K | 12.0K | New | $0 |
| 2022-12-05 | 2022-12-05 | SLS | Burns John Thomas | CAO, Senior VP, Fin | S - Sale | $2.59 | -1,159 | 29.3K | -4% | -$3,002 | |
| 2022-12-05 | 2022-12-05 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | S - Sale | $2.61 | -6,494 | 161.7K | -4% | -$16.9K | |
| 2022-12-05 | 2022-12-05 | SLS | WOOD BARBARA A | EVP, Gen. Counsel, Corp. Sec | S - Sale | $2.59 | -2,153 | 56.3K | -4% | -$5,576 | |
| D | 2022-02-01 | 2022-01-31 | SLS | WOOD BARBARA A | EVP, Gen. Counsel, Corp. Sec | A - Grant | $0.00 | +13.0K | 55.0K | +31% | $0 |
| D | 2022-02-01 | 2022-01-31 | SLS | Wasman Jane | Dir | A - Grant | $0.00 | +1,900 | 1,900 | New | $0 |
| D | 2022-02-01 | 2022-01-31 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +44.0K | 165.2K | +36% | $0 |
| D | 2022-02-01 | 2022-01-31 | SLS | SCHEINBERG DAVID A | Dir | A - Grant | $0.00 | +1,900 | 2,082 | +1,044% | $0 |
| D | 2022-02-01 | 2022-01-31 | SLS | Burns John Thomas | CAO, Senior VP, Fin | A - Grant | $0.00 | +9,600 | 27.2K | +54% | $0 |
| D | 2022-02-01 | 2022-01-31 | SLS | VAN NOSTRAND ROBERT L | Dir | A - Grant | $0.00 | +1,900 | 1,900 | New | $0 |
| D | 2022-02-01 | 2022-01-31 | SLS | Varian John | Dir | A - Grant | $0.00 | +1,900 | 1,900 | New | $0 |
| 2021-12-03 | 2021-12-02 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | S - Sale | $6.25 | -2,120 | 121.2K | -2% | -$13.2K | |
| 2021-12-03 | 2021-12-02 | SLS | WOOD BARBARA A | EVP, Gen. Counsel, Corp. Sec | S - Sale | $6.25 | -847 | 42.0K | -2% | -$5,294 | |
| 2021-12-03 | 2021-12-02 | SLS | Burns John Thomas | VP, Fin, Corp Ctrl | S - Sale | $6.27 | -231 | 17.6K | -1% | -$1,448 |
Purchase Sale Sale after option exercise All abbreviations